Xenex Disinfection Services LLC is a privately held company headquartered in San Antonio, Texas. Xenex was founded by epidemiologists Dr. Mark Stibich and Dr. Julie Stachowiak in August 2008 with the core mission to significantly reduce the number of hospital acquired infections that impact the health and lives of millions of patients and their families, and to become the new standard method for disinfection in the healthcare environment. Since its creation, the company has grown to over 100 employees and Xenex devices are now included in infection control protocols in more than 200 United States hospitals and in over 30 federal healthcare facilities.
The development and commercialization of the Xenex “germ-zapping robot” disinfection system has been the hallmark of the company’s success. This system is a portable device used for advanced disinfection of hospitals, clinics, patient rooms, field hospitals and any other environment that requires decontamination without putting staff at risk. The Xenex robot uses xenon pulsed ultraviolet light, a green technology, to deliver fast, safe, and effective disinfection of the environment. The use of the Xenex robot in hospitals has been shown to significantly decrease patient infections caused by some of the hardiest pathogens that plague the hospital environment.
Since September 2014, Xenex has worked with SMI’s Dr. Anna Kushnir and Bill McCann to educate agency personnel within HHS, DOD, DHS, EPA and other entities as well as Congress about the use of Xenex’s technology in the fight against Ebola specifically and the effectiveness of Xenex’s technology in reducing hospital acquired infections. Dr Kushnir is working with different DOD program managers in order to secure resources, support and procurement by different organizations of Xenex’s products for the near future.
Beginning in 2012, Xenex entered into a rapid growth phase. During this time, a highly experienced senior management team was assembled to rapidly expand the company’s sales force, manufacturing capabilities and develop additional products. Given its expertise and encouraging collaboration with the government, Xenex expects a continuous growth and development of new solutions to save lives and reduce suffering by destroying the deadly pathogens that cause major global health issues.